EE+ POEM Archive
In patients who take non–vitamin K antagonist oral anticoagulants, alteplase is not associated with an increased risk of intracranial bleeds
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "In Patients Who Take Non–vitamin K Antagonist Oral Anticoagulants, Alteplase Is Not Associated With an Increased Risk of Intracranial Bleeds." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315606/all/In_patients_who_take_non–vitamin_K_antagonist_oral_anticoagulants_alteplase_is_not_associated_with_an_increased_risk_of_intracranial_bleeds.
In patients who take non–vitamin K antagonist oral anticoagulants, alteplase is not associated with an increased risk of intracranial bleeds. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315606/all/In_patients_who_take_non–vitamin_K_antagonist_oral_anticoagulants_alteplase_is_not_associated_with_an_increased_risk_of_intracranial_bleeds. Accessed April 17, 2024.
In patients who take non–vitamin K antagonist oral anticoagulants, alteplase is not associated with an increased risk of intracranial bleeds. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315606/all/In_patients_who_take_non–vitamin_K_antagonist_oral_anticoagulants_alteplase_is_not_associated_with_an_increased_risk_of_intracranial_bleeds
In Patients Who Take Non–vitamin K Antagonist Oral Anticoagulants, Alteplase Is Not Associated With an Increased Risk of Intracranial Bleeds [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 April 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315606/all/In_patients_who_take_non–vitamin_K_antagonist_oral_anticoagulants_alteplase_is_not_associated_with_an_increased_risk_of_intracranial_bleeds.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - In patients who take non–vitamin K antagonist oral anticoagulants, alteplase is not associated with an increased risk of intracranial bleeds
ID - 1315606
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315606/all/In_patients_who_take_non–vitamin_K_antagonist_oral_anticoagulants_alteplase_is_not_associated_with_an_increased_risk_of_intracranial_bleeds
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
